Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regorafenib in Asian patients with metastatic colorectal cancer (CONCUR)
NCT01584830Phase 3Completed
- Sponsor
- Bayer
- Start
- Apr 2012
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of regorafenib in colorectal cancer (metastatic) (mCRC), sponsored by Bayer. Started Apr 2012; status: completed.
02
Drugs
regorafenib
03
Conditions
colorectal cancer (metastatic) (mCRC)
Beyond the preview
Go deeper on NCT01584830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01584830.